ST-elevation myocardial infarction late-presenting patients: time for a new paradigm?
Abstract
Timely performed percutaneous coronary angioplasty (PCI) remains the most critical factor predicting favorable outcomes in patients with ST-elevation myocardial infarction (STEMI). Guidelines have traditionally identified the first 12 hours from symptom onset as the “golden window” for PCI. However, recommendations for patients presenting beyond this timeframe remain inconsistent. Late presenters are associated with worse outcomes and significantly higher rates of in-hospital mortality. Notably, the recent COVID-19 pandemic has further increased the prevalence of late presentations. Emerging imaging techniques now offer new opportunities to better characterize both patients and the pathological consequences of late-presented STEMI. Despite this progress, evidence supporting the adoption of imaging-guided strategies remains mixed. These advancements hold the potential to pave the way for personalized management approaches for this heterogeneous patient population soon. In this review, we explore the current evidence regarding the treatment of late presenters and discuss how emerging imaging techniques may transform clinical strategies in this challenging subset of STEMI patients.
References
- Danchin N, Popovic B, Puymirat E, et al. Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme. Eur Heart J 2020;41:858-66. DOI: https://doi.org/10.1093/eurheartj/ehz665
- Terkelsen CJ, Sørensen JT, Maeng M, et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA 2010;304:763-71. DOI: https://doi.org/10.1001/jama.2010.1139
- Wong CK, Bucciarelli-Ducci C. Q waves and failed ST resolution: will intra-myocardial haemorrhage be a concern in reperfusing "late presenting" STEMIs? Int J Cardiol 2015;182:203-10. DOI: https://doi.org/10.1016/j.ijcard.2014.12.057
- Late assessment of thrombolytic efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993;342:759-66. DOI: https://doi.org/10.1016/0140-6736(93)91538-W
- Rovelli F, De Vita C, Feruglio GA, et al. GISSI trial: early results and late follow-up. J Am Coll Cardiol 1987;10:33B-9. DOI: https://doi.org/10.1016/S0735-1097(87)80426-6
- Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 2023;44:3720-6. DOI: https://doi.org/10.1093/eurheartj/ehad191
- Rao SV, Mehran R, Jneid H, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation 2025:151:e771-862.
- Jäger B, Farhan S, Rohla M, et al. Clinical predictors of patient-related delay in the VIENNA ST-elevation myocardial infarction network and impact on long-term mortality. Eur Heart J Acute Cardiovasc Care 2017;6:254-61. DOI: https://doi.org/10.1177/2048872616633882
- Fu R, Li SD, Song CX, et al. Clinical significance of diabetes on symptom and patient delay among patients with acute myocardial infarction—an analysis from China Acute Myocardial Infarction (CAMI) registry. J Geriatr Cardiol 2019;16:395-400.
- Cho KH, Han X, Ahn JH, et al. Long-term outcomes of patients with late presentation of ST-segment elevation myocardial infarction. J Am Coll Cardiol 2021;77:1859-70. DOI: https://doi.org/10.1016/j.jacc.2021.02.041
- Bouisset F, Gerbaud E, Bataille V, et al. Percutaneous myocardial revascularization in late-presenting patients with STEMI. J Am Coll Cardiol 2021;78:1291-305. DOI: https://doi.org/10.1016/j.jacc.2021.07.039
- Meyer MR, Arnold M, Rössler K, et al. Gender differences in patient and system delay for primary percutaneous coronary intervention: current trends in a Swiss ST-segment elevation myocardial infarction population. Eur Heart J Acute Cardiovasc Care 2019;8:283-90. DOI: https://doi.org/10.1177/2048872618810410
- Schulte KJ, Mayrovitz HN. Myocardial infarction signs and symptoms: females vs. males. Cureus 2023;15:e37522. DOI: https://doi.org/10.7759/cureus.37522
- Lim SC, Rahman A, Yaacob NM. Pre-hospital factors influencing time of arrival at emergency departments for patients with acute ST-elevation myocardial infarction. Malays J Med Sci 2019;26:87-98. DOI: https://doi.org/10.21315/mjms2019.26.1.8
- Weininger D, Cordova JP, Wilson E, et al. Delays to hospital presentation in women and men with ST-segment elevation myocardial infarction: a multi-center analysis of patients hospitalized in New York City. Ther Clin Risk Manag 2022;18:1-9. DOI: https://doi.org/10.2147/TCRM.S335219
- Cerrato E, Forno D, Ferro S, Chinaglia A. Characteristics, in-hospital management and outcome of late acute ST-elevation myocardial infarction presenters. J Cardiovasc Med 2017;18:567-71. DOI: https://doi.org/10.2459/JCM.0000000000000527
- Obling L, Frydland M, Hansen R, et al. Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients. Eur Heart J Acute Cardiovasc Care 2018;7:7-15. DOI: https://doi.org/10.1177/2048872617706503
- Roberto M, Radovanovic D, de Benedetti E, et al. Temporal trends in latecomer STEMI patients: insights from the AMIS Plus registry 1997-2017. Rev Esp Cardiol 2020;73:741-8. DOI: https://doi.org/10.1016/j.rec.2019.10.001
- Toscano O, Cosentino N, Campodonico J, et al. Acute myocardial infarction during the COVID-19 pandemic: an update on clinical characteristics and outcomes. Front Cardiovasc Med 2021;8:648290. DOI: https://doi.org/10.3389/fcvm.2021.648290
- Hodas R, Benedek I, Rat N, et al. Impact of COVID-19 pandemic on STEMI networks in Central Romania. Life 2021;11:1004. DOI: https://doi.org/10.3390/life11101004
- Baldi E, Savastano S, Cortese G, et al. Patient voluntarily delays call to emergency medical system for ST-elevation myocardial infarction during COVID-19 pandemic. Int J Cardiol Heart Vasc 2021;35:100824. DOI: https://doi.org/10.1016/j.ijcha.2021.100824
- Otero D, Singam NSV, Barry N, et al. Complication of late presenting STEMI due to avoidance of medical care during COVID-19 pandemic. JACC Case Rep 2020;2(10):1610–1613. doi:10.1016/j.jaccas.2020.05.045. DOI: https://doi.org/10.1016/j.jaccas.2020.05.045
- De Luca G, Verdoia M, Cercek M, et al. Impact of COVID-19 pandemic on mechanical reperfusion for patients with STEMI. J Am Coll Cardiol 2020;76:2321-30. DOI: https://doi.org/10.1016/j.jacc.2020.09.546
- Tam CF, Siu CD, Tse HF. Challenges in management of ST elevation myocardial infarction during COVID-19 pandemic. Cardiol Plus 2021;6:218-30. DOI: https://doi.org/10.4103/2470-7511.334400
- Kamarullah W, Sabrina AP, Rocky MA, Gozali DR. Investigating the implications of COVID-19 outbreak on systems of care and outcomes of STEMI patients: a systematic review and meta-analysis. Indian Heart J 2021;73:404-12. DOI: https://doi.org/10.1016/j.ihj.2021.06.009
- Chandrashekhar Y, Alexander T, Mullasari AS, et al. Resource and infrastructure-appropriate management of ST-segment elevation myocardial infarction in low- and middle-income countries. Circulation 2020;141:2004-25. DOI: https://doi.org/10.1161/CIRCULATIONAHA.119.041297
- Landon BE, Hatfield LA, Bakx P, et al. Differences in treatment patterns and outcomes of acute myocardial infarction for low- and high-income patients in 6 countries. JAMA 2023;329:1088-97. DOI: https://doi.org/10.1001/jama.2023.1699
- Alexander T, Mullasari AS, Joseph G, et al. A System of Care for Patients With ST-Segment Elevation Myocardial Infarction in India: the Tamil Nadu-ST-segment elevation myocardial infarction program. JAMA Cardiol 2017;2:498-505. DOI: https://doi.org/10.1001/jamacardio.2016.5977
- Di Domenicantonio R, Cappai G, Sciattella P, et al. The tradeoff between travel time from home to hospital and door to balloon time in determining mortality among STEMI patients undergoing PCI. PLoS One 2016;11:e0158336. DOI: https://doi.org/10.1371/journal.pone.0158336
- Minha S, Gilutz H, Cohen M, et al. Transfer distance effect on reperfusion: timeline of ST-elevation patients transferred for primary percutaneous coronary intervention. Cardiovasc Revasc Med 2014;15:369-74. DOI: https://doi.org/10.1016/j.carrev.2014.08.003
- French WJ, Granger CB, Henry TD, et al. Emergency interhospital transfer of patients with ST-segment-elevation myocardial infarction: call 9-1-1—the American Heart Association mission: lifeline program. J Am Heart Assoc 2022;11:e026700. DOI: https://doi.org/10.1161/JAHA.122.026700
- Heusch G, Gersh BJ. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J 2017;38:774-84. DOI: https://doi.org/10.1093/eurheartj/ehw224
- Maroko PR, Libby P, Ginks WR, et al. Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis. J Clin Invest 1972;51:2710-6. DOI: https://doi.org/10.1172/JCI107090
- Ginks WR, Sybers HD, Maroko PR, et al. Coronary artery reperfusion. II. Reduction of myocardial infarct size at 1 week after the coronary occlusion. J Clin Invest 1972;51:2717-23. DOI: https://doi.org/10.1172/JCI107091
- Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
- Verma S, Fedak PW, Weisel RD, et al. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation 2002;105:2332-6. DOI: https://doi.org/10.1161/01.CIR.0000016602.96363.36
- De Villiers C, Riley PR. Mouse models of myocardial infarction: comparing permanent ligation and ischaemia-reperfusion. Dis Model Mech 2020;13:dmm046565. DOI: https://doi.org/10.1242/dmm.046565
- Schömig A, Kastrati A, Dirschinger J, et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med 2000;343:385-91. DOI: https://doi.org/10.1056/NEJM200008103430602
- Schömig A, Ndrepepa G, Kastrati A. Late myocardial salvage: time to recognize its reality in the reperfusion therapy of acute myocardial infarction. Eur Heart J 2006;27:1900-7. DOI: https://doi.org/10.1093/eurheartj/ehl174
- Schmidt MR, Rasmussen ME, Bøtker HE. Remote ischemic conditioning for patients with STEMI. J Cardiovasc Pharmacol Ther 2017;22:302-9. DOI: https://doi.org/10.1177/1074248417702481
- Verdouw PD, van den Doel MA, de Zeeuw S, Duncker DJ. Animal models in the study of myocardial ischaemia and ischaemic syndromes. Cardiovasc Res 1998;39:121-35. DOI: https://doi.org/10.1016/S0008-6363(98)00069-8
- Habib GB, Heibig J, Forman SA, et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. Circulation 1991;83:739-46. DOI: https://doi.org/10.1161/01.CIR.83.3.739
- Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987;21:737-46. DOI: https://doi.org/10.1093/cvr/21.10.737
- Prasad A, Gersh BJ, Mehran R, et al. Effect of ischemia duration and door-to-balloon time on myocardial perfusion in ST-segment elevation myocardial infarction: an analysis from HORIZONS-AMI trial. JACC Cardiovasc Interv 2015;8:1966-74. DOI: https://doi.org/10.1016/j.jcin.2015.08.031
- Khan JN, Razvi N, Nazir SA, et al. Prevalence and extent of infarct and microvascular obstruction following different reperfusion therapies in ST-elevation myocardial infarction. J Cardiovasc Magn Reson 2014;16:38. DOI: https://doi.org/10.1186/1532-429X-16-38
- Basso C, Thiene G. The pathophysiology of myocardial reperfusion: a pathologist’s perspective. Heart 2006;92:1559-62. DOI: https://doi.org/10.1136/hrt.2005.086959
- Weir RA, Murphy CA, Petrie CJ, et al. Microvascular obstruction remains a portent of adverse remodeling in optimally treated patients with left ventricular systolic dysfunction after acute myocardial infarction. Circ Cardiovasc Imaging 2010;3:360-7. DOI: https://doi.org/10.1161/CIRCIMAGING.109.897439
- Rios-Navarro C, Marcos-Garces V, Bayes-Genis A, et al. Microvascular obstruction in ST-segment elevation myocardial infarction: looking back to move forward. Focus on CMR. J Clin Med 2019;8:1805. DOI: https://doi.org/10.3390/jcm8111805
- Mather AN, Fairbairn TA, Ball SG, et al. Timing of cardiovascular MR imaging after acute myocardial infarction: effect on estimates of infarct characteristics and prediction of late ventricular remodeling. Radiology 2011;261:116-26. DOI: https://doi.org/10.1148/radiol.11110228
- Gräni C, Stark AW, Fischer K, et al. Diagnostic performance of cardiac magnetic resonance segmental myocardial strain for detecting microvascular obstruction and late gadolinium enhancement in patients presenting after a ST-elevation myocardial infarction. Front Cardiovasc Med 2022;9:909204. DOI: https://doi.org/10.3389/fcvm.2022.909204
- Kumar A, Green JD, Sykes JM, et al. Detection and quantification of myocardial reperfusion hemorrhage using T2*-weighted CMR. JACC Cardiovasc Imaging 2011;4:1274-83. DOI: https://doi.org/10.1016/j.jcmg.2011.08.016
- Wen ZJ, Xin H, Wang YC, et al. Emerging roles of circRNAs in the pathological process of myocardial infarction. Mol Ther Nucleic Acids 2021;26:828-48. DOI: https://doi.org/10.1016/j.omtn.2021.10.002
- Rodrigues JA, Melleu K, Schmidt MM, et al. Independent predictors of late presentation in patients with ST-segment elevation myocardial infarction. Arq Bras Cardiol 2018;111:587-93. DOI: https://doi.org/10.5935/abc.20180178
- McNair PW, Bilsker M, Schooley M, et al. Very late presentation in ST elevation myocardial infarction: predictors and long-term mortality. Int J Cardiol Heart Vasc 2019;22:156-9. DOI: https://doi.org/10.1016/j.ijcha.2019.02.002
- Fan X, Maharjan P, Liu P, Bai L. Effect of primary PCI on the recovery of atrioventricular block in inferior STEMI patients with late presentation (>12 hours): insights from a single center 10-year experience. J Investig Med. 2020;68(5):1011-1014. doi:10.1136/jim-2019-001255 DOI: https://doi.org/10.1136/jim-2019-001255
- Cho KH, Han X, Ahn JH, et al. Long-term outcomes of patients with late presentation of ST-segment elevation myocardial infarction. JACC 2021;77:1859-70. DOI: https://doi.org/10.1016/j.jacc.2021.02.041
- Shenoy N, Devasia T. Comparison of outcomes between early and late presentation of ST-elevation myocardial infarction in patients with cardiogenic shock. Int J Cardiovasc Acad 2024;10:53-9. DOI: https://doi.org/10.4274/ijca.2024.41861
- Fernandes GC, Costa JR, Almeida RF, et al. Determinants of early and late in-hospital mortality after acute myocardial infarction: a subanalysis of the OBTAIN registry. Can J Cardiol 2023;39:531-7. DOI: https://doi.org/10.1016/j.cjca.2022.10.019
- Damluji AA, van Diepen S, Katz JN, et al. Mechanical complications of acute myocardial infarction: a scientific statement from the American Heart Association. Circulation 2021;144:e16-35. DOI: https://doi.org/10.1161/CIR.0000000000000985
- Aoun J, Kleiman NS, Goel SS. (2021). Diagnosis and management of late-presentation ST-elevation myocardial infarction and complications. Interv Cardiol Clin 2021;10:369-80. DOI: https://doi.org/10.1016/j.iccl.2021.03.008
- Fan X, Maharjan P, Liu P, Bai L. Effect of primary PCI on the recovery of atrioventricular block in inferior STEMI patients with late presentation (>12 hours): insights from a single center 10-year experience. J Investig Med. 2020;68(5):1011-1014. doi:10.1136/jim-2019-001255 DOI: https://doi.org/10.1136/jim-2019-001255
- Rittersma SZ, van der Wal AC, Koch KT, et al. Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention. Circulation 2005;111:1160-5. DOI: https://doi.org/10.1161/01.CIR.0000157141.00778.AC
- Yang Y, Li J, Xu W, et al. Thrombus aspirated from patients with ST-elevation myocardial infarction: clinical and angiographic outcomes. J Int Med Res 2016;44:1514-23. DOI: https://doi.org/10.1177/0300060516667373
- Nepper-Christensen L, Lønborg J, Høfsten DE, et al. Benefit from reperfusion with primary percutaneous coronary intervention beyond 12 hours of symptom duration in patients with ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv 2018;11:e006842. DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.118.006842
- Busk M, Kaltoft A, Nielsen SS, et al. Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h. Eur Heart J 2009;30:1322-30. DOI: https://doi.org/10.1093/eurheartj/ehp113
- APEX AMI Investigators, Armstrong PW, Granger CB, et al. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA 2007;297:43-51. DOI: https://doi.org/10.1001/jama.297.1.43
- Alkhalil M, Choudhury RP. Reperfusion treatment in late presentation acute myocardial infarction. Circulation 2018;11:e007287. DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.118.007287
- Mayr A, Bartko P, Reiter C, Toma A. Evolution of myocardial tissue injury: a CMR study over a decade after STEMI. JACC Cardiovasc Imaging 2022;15:1030-42. DOI: https://doi.org/10.1016/j.jcmg.2022.02.010
- Limalanathan S, Eritsland J, Andersen GØ, et al. Myocardial salvage is reduced in primary PCI-treated STEMI patients with microvascular obstruction, demonstrated by early and late CMR. PLoS One 2013;8:e71780. DOI: https://doi.org/10.1371/journal.pone.0071780
- Bigler MR, Tada Y, Billinger M, et al. Algorithm for real-time analysis of intracoronary electrocardiogram. Front Cardiovasc Med 2022;9:930717. DOI: https://doi.org/10.3389/fcvm.2022.930717
- Wong DTL, Bertovic DA, Lee RJ, et al. Intracoronary ECG during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction predicts microvascular obstruction and infarct size. Int J Cardiol 2013;165:61-6. DOI: https://doi.org/10.1016/j.ijcard.2011.07.078
- Li W, He J, Fan J, et al. Prognostic and diagnostic accuracy of intracoronary electrocardiogram recorded during percutaneous coronary intervention: a meta-analysis. BMJ Open 2022;12:e055871. DOI: https://doi.org/10.1136/bmjopen-2021-055871
- Topal DG, Nepper-Christensen L, Lønborg J, et al. Electrocardiogram to predict reperfusion success in late presenters with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. J Electrocardiol 2020;59:74-80. DOI: https://doi.org/10.1016/j.jelectrocard.2020.01.008
- Mahdiui ME, El Mahdiui M, van der Bijl P, et al. Myocardial work, an echocardiographic measure of post myocardial infarct scar on contrast-enhanced cardiac magnetic resonance. Am J Cardiol 2021;151:1-9. DOI: https://doi.org/10.1016/j.amjcard.2021.04.009
- Gvinianidze L, Toulemonde M, Hampson R, et al. Ultrafast myocardial contrast echocardiography for the assessment of coronary artery disease: first in-human study. Circ Cardiovasc Imaging 2024;17:e017267. DOI: https://doi.org/10.1161/CIRCIMAGING.124.017267
- Hathaway QA, Jamthikar AD, Rajiv N, et al. Cardiac ultrasomics for acute myocardial infarction risk stratification and prediction of all-cause mortality: a feasibility study. Echo Res Pract 2024;11:22. DOI: https://doi.org/10.1186/s44156-024-00057-w
- Cong T, Sun Y, Shang Z, et al. Prognostic value of speckle tracking echocardiography in patients with ST-elevation myocardial infarction treated with late percutaneous intervention. Echocardiography 2015;32:1384-91. DOI: https://doi.org/10.1111/echo.12864
- Gaibazzi N, Bianconcini M, Marziliano N, et al. Scar detection by pulse-cancellation echocardiography: validation by CMR in patients with recent STEMI. JACC Cardiovasc Imaging 2016;9:1239-51. DOI: https://doi.org/10.1016/j.jcmg.2016.01.021
- Schömig A, Mehilli J, Antoniucci D, et al. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA 2005;293:2865-72. DOI: https://doi.org/10.1001/jama.293.23.2865
- Ndrepepa G, Kastrati A, Mehilli J, et al. Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms. JAMA 2009;301:487-8. DOI: https://doi.org/10.1001/jama.2009.32
- Gierlotka M, Gasior M, Wilczek K, et al. Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms: a prospective national observational study. Am J Cardiol 2011;107:501-8. DOI: https://doi.org/10.1016/j.amjcard.2010.10.008
- Gimple S, Menon V. Lack of benefit with percutaneous intervention for late persistent occlusion after myocardial infarction: summary of the occluded artery trial. J Cardiovasc Nurs 2008;23:30-3. DOI: https://doi.org/10.1097/01.JCN.0000305055.58129.35
- Dzavík V, Buller CE, Lamas GA, et al. Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial. Circulation 2006;114:2449-57. DOI: https://doi.org/10.1161/CIRCULATIONAHA.106.669432
- Xiu WJ, Yang HT, Zheng YY, et al. Delayed PCI 12 hours after the onset of symptoms is associated with improved outcomes for patients with ST-segment elevation myocardial infarction: a real-world study. J Interv Cardiol 2019;2019:2387929. DOI: https://doi.org/10.1155/2019/2387929
- Koutsoukis A, Kanakakis I. Challenges and unanswered questions in STEMI management. Hellenic J Cardiol 2019;60:211-5. DOI: https://doi.org/10.1016/j.hjc.2019.01.001
- Kastrati A, Coughlan JJ, Ndrepepa G. Primary PCI, late presenting STEMI, and the limits of time. J Am Coll Cardiol 2021;78:1306-8. DOI: https://doi.org/10.1016/j.jacc.2021.08.001
- De Luca L, Veneziano FA, Karaboue M. Late presenters with ST-elevation myocardial infarction: a call to action. J Clin Med 2022;11:5169. DOI: https://doi.org/10.3390/jcm11175169
- Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur Heart J 2018;39:213-60. DOI: https://doi.org/10.1016/j.rec.2017.11.020
- Bi X, Wang B, Tse G, et al. Clinical manifestation of cardiac rupture in patients with ST-segment elevation myocardial infarction: early versus late primary percutaneous coronary intervention. Glob Heart 2022;17:69. DOI: https://doi.org/10.5334/gh.1155
- Park H, Kim HK, Jeong MH, et al. Clinical impacts of inhibition of renin-angiotensin system in patients with acute ST-segment elevation myocardial infarction who underwent successful late percutaneous coronary intervention. J Cardiol 2017;69:216-21. DOI: https://doi.org/10.1016/j.jjcc.2016.03.012
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2025 The Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.